Susheel J Nara

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Richard A Hartz, Vijay T Ahuja, Susheel J Nara, C M Vijaya Kumar, Raju K V L P Manepalli, Sarat Kumar Sarvasiddhi, Swarnamba Honkhambe, Vidya Patankar, Bireshwar Dasgupta, Ramkumar Rajamani, Jodi K Muckelbauer, Daniel M Camac, Kaushik Ghosh, Matthew Pokross, Susan E Kiefer, Jeffrey M Brown, Lisa Hunihan, Michael Gulianello, Martin Lewis, Jonathan S Lippy, Neha Surti, Brian D Hamman, Jason Allen, Walter A Kostich, Joanne J Bronson, John E Macor, Carolyn D Dzierba
Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 Inhibitors. Journal of medicinal chemistry 65 (5) (2022)
Susheel J Nara, Srinivas Jogi, Srinivas Cheruku, Sarkunam Kandhasamy, Firoz Jaipuri, Pavan Kalyan Kathi, Subba Reddy, Sanket Sarodaya, Erica M Cook, Tao Wang, Doree Sitkoff, Karen A Rossi, Max Ruzanov, Susan E Kiefer, Javed A Khan, Mian Gao, Satyanarayana Reddy, Sankara Sivaprasad Lvj, Ramola Sane, Kathy Mosure, Xiaoliang Zhuo, Gary G Cao, Milinda Ziegler, Anthony Azzara, John Krupinski, Matthew G Soars, Bruce Alan Ellsworth, Dean A Wacker
Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic Steatohepatitis. Journal of medicinal chemistry 65 (13) (2022)

Susheel J Nara.css-eqlu8i{font-size:small;padding-left:4px;}